• Users Online: 251
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2022  |  Volume : 24  |  Issue : 3  |  Page : 110-113

Hyperbaric oxygen therapy in frostbite: A case series


1 Squadron Medical Officer, Graded Specialist, Marine & Hyperbaric Medicine, 14th Submarine Squadron/INS Virbahu, Visakhapatnam, Andhra Pradesh, India
2 HoD & Sr. Adv, Department of Marine & Hyperbaric Medicine, INHS Asvini, Mumbai, Maharashtra, India
3 Sr Adv, Department of Marine & Hyperbaric Medicine, O/o DGMS (Navy), Delhi, India
4 Classified Specialist, Department of Reconstructive Surgery, INHS Asvini, Mumbai, Maharashtra, India

Correspondence Address:
Surg Lt Cdr (Dr) Anil Pinninti
School of Naval Medicine, INHS Asvini, Colaba, Mumbai - 400 005, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmms.jmms_23_21

Rights and Permissions

A team of 10 personnel from a mountaineering team has undertaken an expedition to Mt Menthosa at an altitude of 21138 ft. in October 2018. After scaling the peak and in the following days during descent, the three members of the team had developed cold injuries. They were given first aid during descent. Later, they were diagnosed as cases of frostbite. All three personnel were evacuated to a Military Hospital, Delhi, India and were treated with oral vasodilators, antiplatelet drugs, analgesics, and hyperbaric oxygen therapy (HBO2T) was administered at a Recompression chamber at Delhi for 1 week. These personnel were thereafter referred to INHS Asvini for further management and continuation of HBO2T. After 30 sessions of HBO2T administration at this hospital, there was a significant improvement in the wounds of all three personnel with minimal surgical intervention and no major amputation. The treatment of frostbite includes treating hypothermia before thawing of cold injury, nonsteroidal anti-inflammatory drugs, antibiotics, tissue plasminogen activators and iloprost, a potent vasodilator which is used in severe cases. Planning of surgery is vital with the goal of obtaining the best functional outcome. Premature amputation increases morbidity and is likely to lead to poor subsequent function. This article aims to discuss the advantages of HBO2T administration as an adjuvant therapy in the management of frostbite cases along with wound care management.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed70    
    Printed0    
    Emailed0    
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal